D'Angelo S - Search Results

1

Correlation of Tumor Necrosis Factor-α -308G>A Polymorphism with Susceptibility, Clinical Manifestations, and Severity in Behçet Syndrome: Evidences from an Italian Genetic Case-Control Study.

Padula MC, Leccese P, Lascaro N, Radice RP, Limongi AR, Sorrento GG, Carbone T, Padula AA, Martelli G, D'Angelo S. Padula MC, et al. DNA Cell Biol. 2020 Jul;39(7):1104-1110. doi: 10.1089/dna.2020.5361. Epub 2020 Apr 29. DNA Cell Biol. 2020. PMID: 32352842

2

Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab.

Leccese P, Latanza L, D'Angelo S, Padula A, Olivieri I. Leccese P, et al. Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S93. Epub 2011 Sep 27. Clin Exp Rheumatol. 2011. PMID: 21813069 No abstract available.

3

Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab.

Olivieri I, Leccese P, D'Angelo S, Padula A, Nigro A, Palazzi C, Coniglio G, Latanza L. Olivieri I, et al. Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S54-7. Epub 2011 Sep 27. Clin Exp Rheumatol. 2011. PMID: 21968237

4

Low frequency of axial involvement in southern Italian Caucasian children with HLA-B27 positive juvenile onset undifferentiated spondyloarthritis.

Olivieri I, Cutro MS, D'Angelo S, Leccese P, Mennillo GA, Scarano E, Abate R, Palazzi C, Padula A. Olivieri I, et al. Clin Exp Rheumatol. 2012 Mar-Apr;30(2):290-6. Epub 2012 Apr 13. Clin Exp Rheumatol. 2012. PMID: 22325303

5

Late-onset spondyloarthritis: subset that should not be forgotten.

Olivieri I, D'Angelo S, Palazzi C, Leccese P, Padula A. Olivieri I, et al. J Rheumatol. 2012 Jun;39(6):1110-2. doi: 10.3899/jrheum.120184. Epub 2012 May 15. J Rheumatol. 2012. PMID: 22589252 No abstract available.

6

Pharmacoeconomic issues in psoriatic arthritis.

Olivieri I, D'Angelo S, Palazzi C, Padula A, Lubrano E, Mantovani LG. Olivieri I, et al. J Rheumatol Suppl. 2012 Jul;89:103-5. doi: 10.3899/jrheum.120258. J Rheumatol Suppl. 2012. PMID: 22751607 Review.

7

Can we reduce the dosage of biologics in spondyloarthritis?

Olivieri I, D'Angelo S, Padula A, Leccese P, Nigro A, Palazzi C. Olivieri I, et al. Autoimmun Rev. 2013 May;12(7):691-3. doi: 10.1016/j.autrev.2012.08.013. Epub 2012 Aug 23. Autoimmun Rev. 2013. PMID: 22940233 Review.

8

Ochronotic arthropathy of the spine limited to the thoracic section.

Palazzi C, D'Angelo S, Leccese P, Nigro A, Olivieri I. Palazzi C, et al. Rheumatology (Oxford). 2013 May;52(5):799. doi: 10.1093/rheumatology/kes396. Epub 2013 Jan 7. Rheumatology (Oxford). 2013. PMID: 23300332 No abstract available.

9

Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis.

Olivieri I, D'Angelo S, Palazzi C, Leccese P, Nigro A, Padula A. Olivieri I, et al. Reumatismo. 2013 Mar 28;65(1):1-3. doi: 10.4081/reumatismo.2013.1. Reumatismo. 2013. PMID: 23550255 No abstract available.

10

High prevalence of Behçet's disease in southern Italy.

Olivieri I, Leccese P, Padula A, Nigro A, Palazzi C, Gilio M, D'Angelo S. Olivieri I, et al. Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):28-31. Epub 2013 Apr 2. Clin Exp Rheumatol. 2013. PMID: 23557837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

690 results

Search Page

Filters